Cargando…
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition
PURPOSE: Although MAGEC2 was first cloned from a human hepatocellular carcinoma (HCC) cDNA library by serum screening, the detailed attributes of MAGEC2 in HCC have rarely been elucidated. PATIENTS AND METHODS: In this study, The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) datab...
Autores principales: | Gu, Xuefeng, Mao, Yuan, Shi, Chuanbing, Ye, Wei, Hou, Ning, Xu, Li, Chen, Yan, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767874/ https://www.ncbi.nlm.nih.gov/pubmed/31576142 http://dx.doi.org/10.2147/OTT.S213164 |
Ejemplares similares
-
MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
por: Yang, Fan, et al.
Publicado: (2014) -
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer
por: Duan, Fangfang, et al.
Publicado: (2016) -
Establishment of MAGEC2‐knockout cells and functional investigation of MAGEC2 in tumor cells
por: Wang, Jingjing, et al.
Publicado: (2016) -
Study on Attenuating Angiogenesis and Epithelial–Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2
por: Jiang, Sicong, et al.
Publicado: (2018) -
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers
por: Ellegate, James, et al.
Publicado: (2022)